Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Evaluation of Brain Waste Clearance Pathways Using Magnetic Resonance Imaging in Pediatric Patients With White Matter Diseases

N/AActive Not RecruitingNCT06335004
IRCCS Eugenio Medea100 enrolled

Overview

The dilation of perivascular spaces can be the result of various etiopathogenetic processes. White matter atrophy can cause enlargement of these perivascular spaces (PVS) but also obstruction of fluid drainage systems (interstitial fluid, ISF) and metabolites, as evidenced by some recent studies. Focal stagnation of liquids and deposition of toxic material induce tissue hypoxia and neuroglial dysfunction. Dilation of PVS can be associated with changes in white matter and microhemorrhages. We want to study these etiopathogenetic phenomena by implementing specific MRI methods.

Primary objective: the quantification of indirect magnetic resonance markers of altered waste drainage systems using validated scales in patients with white matter disease. Secondary objective: the evaluation of white matter alterations in relation to the known anatomical glymphatic pathways by analyzing both structural and diffusion data.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Glymphatic SystemWhite Matter DiseasePediatric DisorderPerivascular Disease

Interventions

Magnetic resonance imagingDIAGNOSTIC_TEST

Patients will undergo a magnetic resonance imaging for clinical purposes to which additional sequences. Post gadolinium research sequences will be acquired only if intravenous gadolinium needs to be administered for clinical purposes.

Eligibility

Sex: ALLMin age: 9 MonthsMax age: 70 Years
Medical Language ↔ Plain English
Inclusion Criteria: * patients with and without white matter disease * patients willing to participate in research with signed consent form * no age limit (results will be age matched) Exclusion Criteria: * unwilling to participate in research

Locations (1)

Scientific Institute IRCCS Eugenio Medea

Bosisio Parini, Lecco, Italy

Outcomes

Primary Outcomes

Extent of white matter lesions

T1 values of lesions

Time frame: once at recruitment

Number of perivascular spaces

count of perivascular spaces and total volume in disease population

Time frame: once at recruitment

Volume of parasagittal dural space

volume of parasagittal dural space in disease population

Time frame: once at recruitment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.